Press Releases

Other News

Nov 27 2023
Øystein Rekdal, CEO in Lytix Biopharma, presented at Redeye Life Science Day 2023 in Stockholm – 23rd of November
Aug 18 2023
Redeye interviewed Øystein Rekdal about Lytix and his role as CEO
Aug 14 2023
The positive interim Phase II data with LTX-315 from Verrica Pharmaceuticals Inc. (Lytix Biopharma’s licensing partner) stirs attention
Aug 10 2023
Redeye initiates coverage of Lytix Biopharma
May 30 2023
Lytix Biopharma’s innovative and unique solution emphasized in national clinical research report